PALMER, Mass., May 19, 2020 /PRNewswire/ -- Adaptas Solutions,
LLC, a leader in mass spectrometry and analytical instrument
contract design and manufacturing, completed the previously
announced acquisition of L3Harris Technologies' (NYSE: LHX) Applied
Kilovolts and Analytical Instrumentation business.
"We are excited to complete the addition of these highly
strategic assets which immediately expand our mass spectrometer
component offerings and further establish Adaptas as a leading
provider of components, subassemblies, and contract manufacturing
to the global analytical instrumentation market," said Jay Ray, President and CEO of Adaptas
Solutions. "With the CeraMAXTM and Applied
Kilovolts business units now a part of Adaptas, we look forward to
continuing our commitment to driving market-leading innovation in
the mass spectrometry market and to begin leveraging our new
manufacturing presence in Europe
to best support global OEM customers."
This acquisition further enhances Adaptas' manufacturing and
engineering resources, allowing Adaptas to accelerate OEM client
development projects while offering the industry's broadest range
of next generation mass spectrometer detection solutions.
Adaptas Solutions is a portfolio company of Ampersand Capital
Partners. Financial terms of the acquisition were not
disclosed.
About L3Harris Technologies
L3Harris Technologies is
an agile global aerospace and defense technology innovator,
delivering end-to-end solutions that meet
customers' mission-critical needs. The company provides
advanced defense and commercial technologies across air, land, sea,
space and cyber domains. L3Harris has approximately $18 billion in annual revenue and 50,000
employees, with customers in 130 countries. Additional
information is available at www.l3harris.com
About Adaptas Solutions, LLC
Adaptas Solutions,
LLC is a strategic OEM supplier for key products and manufacturing
service for analytical and laboratory equipment manufacturers.
Adaptas' manufacturing vertical integration strategy allows
for rapid to-market product development and best in class costing
while delivering high quality products and services.
Additional information is available at www.adaptas.com
About Ampersand Capital Partners
Founded in 1988,
Ampersand is a middle market private equity firm dedicated to
growth-oriented investments in the healthcare sector. With
offices in Boston and Amsterdam, Ampersand leverages its unique
blend of private equity and operating experience to build value and
drive superior long-term performance alongside its portfolio
company management teams. Ampersand has helped build numerous
market-leading companies across each of our core healthcare
sectors, including Brammer Bio,
Confluent Medical, Genewiz, Talecris Biotherapeutics and
Viracor-IBT Laboratories. For more information, please visit
www.ampersandcapital.com.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/adaptas-solutions-completes-acquisition-of-applied-kilovolts-and-analytical-instrumentation-business-from-l3harris-technologies-301061415.html
SOURCE Adaptas Solutions, LLC